https://scholars.lib.ntu.edu.tw/handle/123456789/565343
標題: | Use of seroprevalence to guide dengue vaccination plans for older adults in a dengue non-endemic country | 作者: | Pan, Yi-Hua Liao, Mei-Ying Chien, Yu-Wen Ho, Tzong-Shiann Ko, Hui-Ying Yang, Chin-Rur Chang, Shu-Fen Yu, Chia-Yi Lin, Shu-Yu Shih, Pin-Wei Shu, Pei-Yun Chao, Day-Yu Pan, Chao-Ying Chen, Hong-Ming Perng, Guey-Chuen CHIA-CHI KU King, Chwan-Chuen |
公開日期: | 四月-2021 | 卷: | 15 | 期: | 4 | 來源出版物: | PLoS neglected tropical diseases | 摘要: | A shift in dengue cases toward the adult population, accompanied by an increased risk of severe cases of dengue in the elderly, has created an important emerging issue in the past decade. To understand the level of past DENV infection among older adults after a large dengue outbreak occurred in southern Taiwan in 2015, we screened 1498 and 2603 serum samples from healthy residents aged ≥ 40 years in Kaohsiung City and Tainan City, respectively, to assess the seroprevalence of anti-DENV IgG in 2016. Seropositive samples were verified to exclude cross-reaction from Japanese encephalitis virus (JEV), using DENV/JEV-NS1 indirect IgG ELISA. We further identified viral serotypes and secondary DENV infections among positive samples in the two cities. The overall age-standardized seroprevalence of DENV-IgG among participants was 25.77% in Kaohsiung and 11.40% in Tainan, and the seroprevalence was significantly higher in older age groups of both cities. Although the percentages of secondary DENV infection in Kaohsiung and Tainan were very similar (43.09% and 44.76%, respectively), DENV-1 and DENV-2 spanned a wider age range in Kaohsiung, whereas DENV-2 was dominant in Tainan. As very few studies have obtained the serostatus of DENV infection in older adults and the elderly, this study highlights the need for further investigation into antibody status, as well as the safety and efficacy of dengue vaccination in these older populations. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/565343 | ISSN: | 19352727 | DOI: | 10.1371/journal.pntd.0009312 | SDG/關鍵字: | dengue vaccine; immunoglobulin G; immunoglobulin G antibody; monoclonal antibody; yh0023; virus antibody; adult; aged; Article; blood biochemistry; cross reaction; dengue; Dengue virus; Dengue virus 1; Dengue virus 2; enzyme linked immunosorbent assay; epidemic; female; health care planning; human; Japanese encephalitis virus; kidney function test; major clinical study; male; middle aged; multicenter study; optical density; retrospective study; risk factor; sensitivity and specificity; serodiagnosis; serological surveillance; seroprevalence; serotype; serotyping; urinalysis; vaccination; Vero cell line; virus detection; virus load; virus transmission; Zika virus; age; blood; dengue; Dengue virus; genetics; immunology; multivariate analysis; seroepidemiology; statistical model; Taiwan; very elderly; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; Dengue; Dengue Virus; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Logistic Models; Male; Middle Aged; Multivariate Analysis; Seroepidemiologic Studies; Taiwan |
顯示於: | 免疫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。